PARCC 2.0: Innovation Serving Cardiovascular and Renal Health

PARCC 2.0: PARCC reaches a new milestone!

We are proud to announce a massive investment of over €1.5 million to propel our research capabilities to new heights. The PARCC 2.0 project is coming to fruition through the acquisition of state-of-the-art equipment across four of our major core facilities. These next-generation tools will enable our researchers to push the boundaries of imaging, precision diagnostics, and cellular analysis.

🔬 A closer look at our new acquisitions:

PARCC-PICO (Confocal and Multiphoton Imaging)

• ✨ New: Super-resolution microscope.

• 👩‍🔬 Facility Managers: Yunling Xu | Eric Camerer

• 🙏 Funding: Fondation Lefoulon Delalande – Institut de France

PARCC-PathDX (Precision Pathology and Diagnostics)

• ✨ New: CosMx SMI (Spatial Transcriptomics).

• 👩‍🔬 Facility Managers: J. Dagobert, A. Certain & F. Mezine | Alexandre Loupy

• 🙏 Funding: DIM AI4IDF 2026 & Université Paris Cité – Inserm

PARCC-PH2I (Histology Immunostaining and Tissue Imaging)

• ✨ New: High-throughput Hyperplex platform.

• 👩‍🔬 Facility Managers: Corinne Lesaffre | Olivia Lenoir, Eric Tartour

• 🙏 Funding: Région IDF (SESAME) & Université Paris Cité & PEPR RNA VASC & Inserm

PARCC-CYTO (Flow Cytometry)

• ✨ New: Spectral cytometer.

• 👩‍🔬 Facility Managers: Camille Knops | Corine Tanchot, Stephane Camus

• 🙏 Funding: Université Paris Cité – Inserm

👉 Want to learn more about our technical capabilities? Contact our facility managers.